Department of Gynecology, Children's Minnesota, Minneapolis, Minnesota.
Department of Gynecology, Children's Minnesota, Minneapolis, Minnesota.
J Pediatr Adolesc Gynecol. 2024 Aug;37(4):444-447. doi: 10.1016/j.jpag.2024.05.003. Epub 2024 May 18.
The aim of this quality improvement (QI) project was to assess postoperative narcotic use after pediatric gynecologic surgeries and establish standard postoperative opioid dosing. Through standard dosing, we hoped to decrease variability in postoperative opioid prescriptions and decrease excess opioid doses in the community.
This quality improvement project was approved by the Children's Minnesota institutional review board. Counseling on postoperative pain management was provided pre- and postoperatively. At the 2-week postoperative visit, patients were asked about the number of opioid doses used and pain control satisfaction. Baseline data were collected for 6 months, with surgeons prescribing the number of opioid doses on the basis of their personal preference. After reviewing the prescribing practices and number of doses used, standard opioid doses were established, and data collection was repeated.
Complete data were recorded for 30 cases before implementation of standard doses and for 29 cases after implementation. Standardized opioid dosing resulted in a 30% decrease in total opioid doses in circulation (252 to 176 doses; P = .014) and a 15% reduction in excess doses in circulation (162 to 137 doses). Forty-three percent of patients did not use any opioid doses. There was no significant difference (P = .8818) in patient pain control satisfaction rating.
Standard opioid dose prescribing is feasible for common pediatric gynecologic surgeries without affecting patient pain control satisfaction. Opioid dose standardization may decrease opioid circulation within the community. Approximately 2 of every 5 patients used 0 opioid doses, which suggests that a further reduction in the standard dose prescriptions is possible.
本质量改进(QI)项目旨在评估小儿妇科手术后的术后阿片类药物使用情况,并建立标准术后阿片类药物剂量。通过标准剂量,我们希望减少术后阿片类药物处方的变异性,并减少社区中过量的阿片类药物剂量。
本质量改进项目已获得明尼苏达州儿童医院机构审查委员会的批准。在术前和术后提供有关术后疼痛管理的咨询。在术后 2 周就诊时,询问患者使用阿片类药物的剂量和疼痛控制满意度。收集了 6 个月的基线数据,外科医生根据个人喜好开具阿片类药物的剂量。在审查了处方实践和使用的剂量后,确定了标准阿片类药物剂量,并重复了数据收集。
在实施标准剂量之前,完整记录了 30 例患者的数据,在实施标准剂量之后,完整记录了 29 例患者的数据。标准化阿片类药物剂量导致循环中的总阿片类药物剂量减少了 30%(从 252 剂减少到 176 剂;P =.014),循环中的过量剂量减少了 15%(从 162 剂减少到 137 剂)。43%的患者未使用任何阿片类药物剂量。患者疼痛控制满意度评分无显著差异(P =.8818)。
在不影响患者疼痛控制满意度的情况下,为常见小儿妇科手术开具标准阿片类药物剂量是可行的。阿片类药物剂量标准化可能会减少社区内阿片类药物的流通。大约每 5 名患者中有 2 名使用了 0 剂阿片类药物,这表明进一步减少标准剂量处方是可能的。